EP 1645-AN ANTI-CD4MAB-FRAGMENT - FOR IMAGING CHRONIC INFLAMMATION IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS - SAFETY EVALUATION OF CARDIOVASCULAR DATA FROM A FIRST IN MAN BAYESIAN APPROACH CLINICAL TRIAL

被引:0
|
作者
Siegert, Joachim [1 ]
Hesse, Swen [2 ]
Schindler, Christoph [1 ]
Idelevich, Evgeny [1 ]
Hillger, Christiane [1 ]
Steinhoff, Karen G. [2 ]
Wirkner, Kerstin [3 ]
Pigla, Ullrich [3 ]
Sabri, Osama [2 ]
Kirch, Wilhelm [1 ]
机构
[1] Tech Univ Dresden, Fac Med, Inst Clin Pharmacol, Dresden, Germany
[2] Univ Leipzig, Dept Nucl Med, Leipzig, Germany
[3] Biotectid GmbH, Leipzig, Germany
来源
JOURNAL OF CLINICAL PHARMACOLOGY | 2009年 / 49卷 / 09期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
149
引用
收藏
页码:1125 / 1125
页数:1
相关论文
共 4 条
  • [1] Results of an adaptive first in man proof of concept study (Bayesian approach) for imaging chronic inflammation in patients with active rheumatoid arthritis with an anti-CD4mAB-Fragment (EP 1645)
    Siegert, Joachim
    Hesse, Swen
    Schindler, Christoph
    Idelevich, Evgeny
    Brecht, Beate
    Bocking, Wolfgang
    Laub, Rudiger
    Pigla, Ullrich
    Sabri, Osama
    Kirch, Wilhelm
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (09): : 1119 - 1119
  • [2] Efficacy Data of an Adaptive 1st in Man Study (Bayesian Approach) for Imaging Chronic Inflammation in Patients with Active Rheumatoid Arthritis with an Anti-Cd4mab-Fragment (Ep 1645)
    Siegert, Joachim
    Hesse, Swen
    Schindler, Christoph
    Idelevich, Evgeny
    Brecht, Beate
    Wirkner, Kerstin
    Laub, Ruediger
    Pigla, Ullrich
    Sabri, Osama
    Kirch, Wilhelm
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 104 (06) : 524 - 524
  • [3] Imaging of chronic inflammation with an anti-CD4MAB fragment (EP 1645) - results of an adaptive study (Bayesian approach) in patients with active rheumatoid arthritis
    Siegert, J.
    Hesse, S.
    Schindler, C.
    Idelevich, E.
    Brecht, B.
    Laub, R.
    Pigla, U.
    Sabri, O.
    Kirch, W.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 92 - 93
  • [4] First results of a first-in-man proof of concept study of an anti-CD4mAb-fragment for the imaging of chronic inflammation in patients with active rheumatoid arthritis
    Siegert, J.
    Brecht, B.
    Hesse, S.
    Schindler, C.
    Pigla, U.
    Sabri, O.
    Kirch, W.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (05) : 369 - 369